We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Eirx Therap. | LSE:ERX | London | Ordinary Share | GB00B0XQBS97 | ORD 0.001P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.015 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:8663O
AIM
27 February 2008
NOTICE
(122)
27/02/2008 1:15pm
TEMPORARY SUSPENSION OF TRADING ON AIM
EIRX THERAPEUTICS PLC
Due to the continuation of the situation notified by the London Stock Exchange
("the Exchange") in the announcement on 25 February 2008 (RNS Number 6334O) and
the continuing delay in settlement of all trades in the Company's AIM
securities, trading on AIM for the under-mentioned securities has been
temporarily suspended with immediate effect.
Ordinary Shares of 0.001p each (B0XQBS9)(GB00B0XQBS97)
fully paid
As previously stated on 25 February 2008, the Exchange has no reason to believe
that this matter involves or affects the Company.
The Exchange will make a further announcement as soon as possible.
If you have any queries relating to the above, please contact AIM Regulation at
the London Stock Exchange on 020 7797 4154
AIM Regulation
Ref: AIMNOT122
This information is provided by RNS
The company news service from the London Stock Exchange
END
EXCUBAORWRRUUAR
1 Year Eirx Therapeutics Chart |
1 Month Eirx Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
